Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITPR3 | Q14573 | 8/20 | 0.89 |
| ▸ | ITPR2 | Q14571 | 4/20 | 0.89 |
| ▸ | ITPR1 | Q14643 | 4/20 | 0.89 |
| ▸ | INPP5A | Q14642 | 3/20 | 0.84 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.83 |
| ▸ | INPPL1 | O15357 | 1/20 | 0.75 |
| ▸ | AKT1 | P31749 | 1/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7538 | 1.00 | ITPR3 (0.89) | ITPR3ITPR2ITPR1INPP5ASMPD1 | |
| SCHEMBL9093315 | 1.00 | ITPR3 (0.89) | ITPR3ITPR2ITPR1INPP5ASMPD1 | |
| SCHEMBL8443842 | 1.00 | ITPR3 (0.89) | ITPR3ITPR2ITPR1INPP5ASMPD1 | |
| SCHEMBL17827496 | 1.00 | ITPR3 (0.89) | ITPR3ITPR2ITPR1INPP5ASMPD1 | |
| SCHEMBL3472015 | 1.00 | ITPR3 (0.89) | ITPR3ITPR2ITPR1INPP5ASMPD1 | |
| SCHEMBL2036332 | 1.00 | ITPR3 (0.89) | ITPR3ITPR2ITPR1INPP5ASMPD1 | |
| SCHEMBL113868 | 1.00 | ITPR3 (0.89) | ITPR3ITPR2ITPR1INPP5ASMPD1 | |
| SCHEMBL235876 | 1.00 | ITPR3 (0.89) | ITPR3ITPR2ITPR1INPP5ASMPD1 | |
| SCHEMBL14396732 | 1.00 | ITPR3 (0.89) | ITPR3ITPR2ITPR1INPP5ASMPD1 | |
| SCHEMBL9094343 | 1.00 | ITPR3 (0.89) | ITPR3ITPR2ITPR1INPP5ASMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0505452-B1 | USE OF INOSITOLPHOSPHATES FOR PREPARING MEDICAMENT | PERSTORP AB (SE) | 1996-06-19 | — | — | EP | claimed |
| US-5342832-A | Use of mono and di inositolphosphates for treating inflammation | PERSTORP AB (SE) | 1994-08-30 | — | — | US | claimed |
| EP-0505452-A1 | USE OF INOSITOLPHOSPHATES FOR PREPARING MEDICAMENT. | PERSTORP AB (SE) | 1992-09-30 | — | — | EP | claimed |
| WO-1991009601-A1 | USE OF INOSITOLPHOSPHATES FOR PREPARING MEDICAMENT | PERSTORP AB (SE) | 1991-07-11 | — | — | WO | claimed |
| EP-0505452-B1 | USE OF INOSITOLPHOSPHATES FOR PREPARING MEDICAMENT | PERSTORP AB (SE) | 1996-06-19 | — | — | EP | disclosed |
| US-5342832-A | Use of mono and di inositolphosphates for treating inflammation | PERSTORP AB (SE) | 1994-08-30 | — | — | US | disclosed |
| EP-0505452-A1 | USE OF INOSITOLPHOSPHATES FOR PREPARING MEDICAMENT. | PERSTORP AB (SE) | 1992-09-30 | — | — | EP | disclosed |
| WO-1991009601-A1 | USE OF INOSITOLPHOSPHATES FOR PREPARING MEDICAMENT | PERSTORP AB (SE) | 1991-07-11 | — | — | WO | disclosed |